3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Breast
1
Conditions
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
Multiple Endocrine Neoplasia Type 1
1
Hyperglycemia
1
Diabetes Mellitus, Type 2
1
Breast Neoplasms
1
Interventions
Insulin Glargine
2
Insulin
2
Alpelisib
2
ziprasidone
1
relacorilant
1
pembrolizumab
1
exemestane
1
Vildagliptin
1
Tamoxifen
1
Olanzapine
1
Metformin
1
Letrozole
1
Insulin Lispro
1
Injections
1
Fulvestrant
1
DNA, Ribosomal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Hyperglycemia
×
Vildagliptin
×
Clear all
NCT04300790
2025-07-29
METALLICA
MedSIR
Phase 2
Completed
69 enrolled